Aleva Neurotherapeutics Company

Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity,translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor.
Technology: Neuromodulation
Industry: NeuroTech
Headquarters: Vaud
Founded Date: 2008
Employees Number: 11-50
Funding Status: N/A

Visit Website
Register and Claim Ownership